Investors

Press Releases

All Releases

View Summary Regeneron Announces Upcoming 2016 Investor Conference Presentation
Feb 2, 2016
PDF 9.9 KB Add to Briefcase
  Regeneron and Sanofi Announce Publication of Positive Phase 2 Dupilumab Data in the Journal of the American Medical Association
Feb 2, 2016
PDF 66.3 KB Add to Briefcase
View Summary Regeneron to Report Fourth Quarter and Full Year 2015 Financial and Operating Results and Host Conference Call and Webcast on February 9, 2016
Jan 26, 2016
PDF 9.4 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Sarilumab Biologics License Application Accepted for Review by US FDA
Jan 8, 2016
PDF 162.0 KB Add to Briefcase
View Summary Regeneron Announces Presentation at the 34th Annual J.P. Morgan Healthcare Conference
Jan 7, 2016
PDF 68.0 KB Add to Briefcase
View Summary Regeneron Mourns Passing of Dr. Alfred G. Gilman, Board Member and Nobel Laureate
Dec 27, 2015
PDF 9.6 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce UnitedHealth Group Selects Praluent® (alirocumab) Injection for Preferred Access
Dec 11, 2015
PDF 20.2 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled
Nov 24, 2015
PDF 20.7 KB Add to Briefcase
View Summary Regeneron Celebrates Patient Innovation and Growth in New York State
Nov 12, 2015
PDF 5.9 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce New Praluent® (alirocumab) Injection Analyses Presented at AHA Scientific Sessions 2015
Nov 10, 2015
PDF 21.8 KB Add to Briefcase
View Summary Regeneron and Sanofi Present Results from Pivotal Phase 3 Study of Sarilumab at American College of Rheumatology Annual Meeting
Nov 8, 2015
PDF 21.7 KB Add to Briefcase
View Summary New Survey of U.S. Adults with Diabetes Reveals Less than Half Understand Their Risk for Vision Loss
Nov 5, 2015
PDF 12.3 KB Add to Briefcase
View Summary Regeneron and Sanofi to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015
Nov 5, 2015
PDF 92.2 KB Add to Briefcase
View Summary Regeneron Reports Third Quarter 2015 Financial and Operating Results
Nov 4, 2015
PDF 39.9 KB Add to Briefcase
View Summary Regeneron Announces EU Approval of EYLEA® (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization
Oct 30, 2015
PDF 17.3 KB Add to Briefcase
View Summary Regeneron Named Among Top Two Global Biopharmaceutical Employers by Science Magazine for Fifth Year in a Row
Oct 29, 2015
PDF 7.0 KB Add to Briefcase
View Summary Regeneron Announces Presentation at the 24th Annual Credit Suisse Healthcare Conference
Oct 23, 2015
PDF 7.7 KB Add to Briefcase
View Summary Regeneron Announces an Additional $350 Million Investment and 200 New Jobs in Limerick by End-2017
Oct 19, 2015
PDF 15.6 KB Add to Briefcase
View Summary Regeneron to Report Third Quarter 2015 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2015
Oct 8, 2015
PDF 8.2 KB Add to Briefcase
View Summary Regeneron and Sanofi Announce Publication of Positive Phase 2b Dupilumab Data in The Lancet
Oct 8, 2015
PDF 17.5 KB Add to Briefcase
Showing 1-20 of 310 Page: 1 2 3 4 5 ... 16  Next 20
Add to Briefcase = add release to Briefcase


Close
Form content here please :)